EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Crossroads between autoimmunity and cancer: underlying mechanisms and clinical implications

Ada Gjyrezi iD, Charalampos Skarlis, Clio Mavragani, Paraskevi Giannakakou iD

Physiological Reviews · 2026

DOI: 10.1152/physrev.00012.2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Physiological Reviews, 2026. Verfasst von Ada Gjyrezi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Hematology Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, New York, United States. Hauptthemen laut MEDLINE: Neoplasms, Autoimmunity, Autoimmune Diseases. Die Arbeit nennt 429 Literaturangaben. Gefördert von: NCI NIH HHS, U.S. Department of Defense (DOD), HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases arise from an aberrant immune response against self-antigens, whereas cancer often develops when the immune system fails to effectively detect and destroy malignant cells. Although historically viewed as distinct entities with opposing immune mechanisms, recent findings highlight significant overlaps in their immunological pathways. This review explores the intricate interplay between autoimmunity and cancer, focusing on immune surveillance, checkpoint regulation, cytokine signaling, and genetic susceptibility. In addition, we discuss epidemiological links, including the heightened risk of malignancy in patients with autoimmune disorders and the autoimmune manifestations often triggered by cancer immunotherapies. We place particular emphasis on shared molecular signatures, predictive biomarkers, and the bidirectional immune modulation that arises from checkpoint inhibitors and biologic agents. Finally, we address the major clinical challenges in managing patients who present with both conditions and propose future research directions aimed at refining immunotherapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAutoimmunityAutoimmune DiseasesHumansAnimalsImmunotherapyGenetic Predisposition to Disease

Stichwörter der Autor:innen

autoimmune diseasescancercancer immunotherapyimmune dysregulationimmunosurveillance

Autor:innen und Institutionen

  • Department of Medicine, Division of Hematology Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, New York, United States.
  • Department of Physiology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Joint Academic Rheumatology Program, National and Kapodistrian University of Athens, Athens, Greece.

ORCID-Profile: Ada Gjyrezi, Paraskevi Giannakakou

Förderung

  • NCI NIH HHS
  • U.S. Department of Defense (DOD)
  • HHS | National Institutes of Health

Zitieren

APA

Gjyrezi, A., Skarlis, C., Mavragani, C., & Giannakakou, P. (2026). Crossroads between autoimmunity and cancer: underlying mechanisms and clinical implications. Physiological Reviews. https://doi.org/10.1152/physrev.00012.2025

Vancouver

Gjyrezi A, Skarlis C, Mavragani C, Giannakakou P. Crossroads between autoimmunity and cancer: underlying mechanisms and clinical implications. Physiological Reviews. 2026. doi:10.1152/physrev.00012.2025

BibTeX
@article{Gjyrezi2026,
  author = {Gjyrezi, Ada and Skarlis, Charalampos and Mavragani, Clio and Giannakakou, Paraskevi},
  title = {Crossroads between autoimmunity and cancer: underlying mechanisms and clinical implications},
  journal = {Physiological Reviews},
  year = {2026},
  doi = {10.1152/physrev.00012.2025}
}
Kostenlos starten →